Altman Advisors, Inc. Illumina, Inc. Transaction History

Altman Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	SELL	$187.24 - $242.74 $98,862 - $128,166	-528 Reduced 12.09%	3,841 $776,000
Q3 2022 Nov 07, 2022	BUY	$177.23 - $227.44 $16,127 - $20,697	91 Added 2.13%	4,369 $834,000
Q2 2022 Aug 08, 2022	BUY	$181.58 - $368.0 $36,316 - $73,600	200 Added 4.9%	4,278 $937,000
Q1 2022 May 09, 2022	BUY	$303.87 - $423.8 $6,077 - $8,476	20 Added 0.49%	4,078 $1.43 Million
Q4 2021 Feb 08, 2022	BUY	$347.28 - $421.83 $19,100 - $23,200	55 Added 1.37%	4,058 $1.49 Million
Q3 2021 Nov 09, 2021	BUY	$405.61 - $524.84 $6,489 - $8,397	16 Added 0.4%	4,003 $1.66 Million
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $89,854 - $116,041	241 Added 6.43%	3,987 $2.02 Million
Q1 2021 May 14, 2021	SELL	$361.28 - $504.76 $59,611 - $83,285	-165 Reduced 4.22%	3,746 $1.44 Million
Q4 2020 Feb 10, 2021	BUY	$292.7 - $370.96 $15,220 - $19,289	52 Added 1.35%	3,911 $1.45 Million
Q3 2020 Nov 13, 2020	BUY	$268.51 - $400.74 $1.04 Million - $1.55 Million	3,859 New	3,859 $1.19 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Altman Advisors, Inc. with notifications on news.